Global Regulatory Reach DLRC operates from UK, Germany, and US offices, serving life science developers from startups to top global pharma. This suggests sales opportunities across multiple regulatory environments and cross-border market access needs, including compliance, submissions, and regional strategy.

Regulatory and HTA Integration The firm combines regulatory affairs, HTA, and market access to support products from non-clinical through post-approval lifecycle management. This positions DLRC to pitch integrated services to companies seeking streamlined evidence generation, payer engagement, and faster patient access across markets.

Awarded Quality and Sustainability DLRC carries Queen’s and King’s Awards for Enterprise, ISO 9001, Investors in People Silver, Cyber Essentials, and SBTi validated targets with Planet Mark monitoring. This credibility can be leveraged to win business from risk-averse biopharma and medtech firms prioritizing quality, governance, and sustainable practices.

Growth and Leadership Recent leadership addition in the US and global team expansion indicate active growth and investment in capabilities. This signals readiness to take on larger, cross-border projects and upsell advisory services to mid-to-large customers seeking US market entry or expansion.

Financial Footprint Revenue range of 25 to 50 million with a mid-sized employee base positions DLRC as a scalable partner for mid-market life science companies needing seasoned regulatory and market access expertise without the overhead of larger CROs.